Senior Scientist, Oncology Discovery Biology at Bristol-Myers Squibb

Seattle, Washington, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s Degree with 6+ years of relevant academic and/or industry experience, or Master’s Degree with 4+ years of relevant academic and/or industry experience, or Ph.D
Expertise in immunology, particularly T cell immunology
Ability to identify and validate novel targets for T cell engagers
Experience designing, developing, and executing novel in vitro and ex vivo cell-based assays/models
Knowledge of T cell biology to develop next-generation T cell engagers
Ability to design and implement critical studies for hypothesis-driven research
Strong collaboration skills in a matrixed, multidisciplinary environment
Excellent communication and interpersonal skills for presenting complex concepts to diverse audiences and driving alignment with stakeholders

Responsibilities

Identify and validate novel targets for development of T cell engagers
Independently design, develop, and execute novel in vitro and ex vivo cell-based assays/models to evaluate the efficacy and specificity of T cell engagers
Apply knowledge of T cell biology to develop next-generation T cell engagers with improved efficacy and safety profiles
Design and implement critical studies required to drive hypothesis-driven research
Collaborate across multiple projects/roles in a matrixed environment
Present complex concepts to a range of audiences including governance and full team project meetings
Utilize excellent communication and interpersonal skills to drive collaboration and alignment with key stakeholders

Skills

Oncology

Discovery Biology

Cancer Biology

Immuno-oncology

In Vitro Models

In Vivo Models

Ex Vivo Models

Biomarkers

Translational Medicine

Drug Discovery

Cell Therapy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free